Jim Cramer Says This Cannabis Stock is Being Unfairly Dragged Down By Cannabis ETFs The Mad Money Host Gave the Stock a 'Booyah' and Said Investors Should Consider Owning It... read more →
GW Pharmaceuticals (NASDAQ: GWPH) announced this morning that the European Commission has approved the marketing authorization for the company's plant-derived CBD-based epilepsy drug Epidyolex. Epidyolex was created to treat seizures... read more →
